Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Siilo is a digital health company that built a secure, compliant messaging and collaboration platform for healthcare professionals and care teams. The product enables physicians, nurses, and healthcare organizations to communicate about patient care, share medical knowledge, and coordinate workflows in a privacy-conscious environment designed for clinical use. Founded in the Netherlands, Siilo grew into one of Europe’s best-known medical messaging networks before being acquired by Doctolib in 2023. Following the acquisition, the product has been transitioned under the Doctolib Connect brand, while continuing to serve healthcare professionals with secure communication and organizational collaboration tools. Siilo is not a therapeutics developer; it is a commercial healthcare software and platform business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Siilo Holding.